
About
Xedev is a CDMO in Zele, Belgium that develops and manufactures drug products for pharmaceutical projects. It supports formulation, analytical testing, preclinical manufacturing, and clinical batches for Phase I and II studies.
Services
Drug product development
Formulation and process development for solid drug products, including custom and scalable solutions.
Solid dosage form development
Development of powders, granules, tablets, capsules, inhalables, and injectables.
Improved solubility and bioavailability development
Development of amorphous solid dispersions and other enabling technologies to improve solubility and bioavailability.
Analytical testing
R&D analytical testing, method verification, qualification and validation, QC batch release, and stability studies.
Spray drying development
Spray drying for screening, amorphous solid dispersions, inhalation/nasal applications, taste masking, and encapsulation.
Targeted release profile development
Development of controlled and targeted release formulations for specific sites or release rates.
Oral peptide and biologics formulation
Formulation development for oral peptides and biologics.
Drug product manufacturing
Manufacturing of preclinical and clinical drug product batches and support for scale-up and tech transfer.
3 more services
- Preclinical manufacturing
- Clinical manufacturing
- Scale-up and tech transfer
- What to send
- API
- Liquid feeds such as solutions, suspensions, or emulsions
- Minimums and prices
- Less than 10 mg per batch
Capabilities
- Assays and studies
- Peptides
- Process development
- Antibodies
- PK/PD
- Solubility studies
- Dissolution testing
13 more
- Assay
- Impurities and related substances
- Forced degradation
- Content uniformity
- Residual solvent analysis
- Moisture analysis
- Microbiological testing
- Particle size distribution
- Morphology and shape
- DVS (hygroscopicity)
- Powder flow properties
- Compressibility
- XRPD
- Scale and capacity
- Milligram-scale testing
- Less than 10 mg per batch
- Manufacturing of R&D batches
- Clinical batches for Phase I and Phase II
Instruments and platforms
- Karl Fischer titration
- XRPD
- mDSC
- FTIR
- Raman
Modalities and species
- Modalities
- Small molecule
- Antibody
- Peptide
- LNP / formulation
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: Phase I and II clinical batches
Details
- Type
- CDMO
- Founded
- 1994
- Address
- Poldergotestraat 4 9240 Zele, Belgium
- General enquiry
- info@xedev.com on their site